Kymera Therapeutics, Inc. Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.

KYMR

Helyezés a részvények között #2179
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Részvényárfolyam
$114.06
Piaci kapitalizáció
$9.38B
Változás (1 nap)
5.54%
Változás (1 év)
88.52%
Ország
US
Kereskedés Kymera Therapeutics, Inc. (KYMR)

Kategória

Healthcare
Kymera Therapeutics, Inc. (KYMR) osztalékhozamának története
Kymera Therapeutics, Inc. (tőzsdei szimbólum: KYMR) osztalékhozama (TTM) 2023-12-31 állapot szerint: 0.00%
Átlagos osztalékhozam az elmúlt 5 évben: 0.00%
Kymera Therapeutics, Inc. (KYMR) osztalékhozamainak története 2018 és 2026 között
Éves záró osztalékhozam (TTM)
Év Osztalékhozam Változtassa meg
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
Hasonló cégek vagy versenytársak osztalékhozamai (TTM)
Vállalat Osztalékhozam Ország
0.00%
US
0.00%
US
2.17%
AU
0.00%
CH
0.00%
NL